treated PDAC model mice with macrophages induced by TMAO and found that tumor burden was reduced by more than 2.4 times compared to mice receiving control macrophage treatment, with significant upregulation of Interferon-γ, CD103, and CD44 on CD8+ and CD4+ cells. This evidence concerns the gene CD8A and neoplasm.